Acute Coryza
Acute coryza is an acute viral infection of the upper respiratory tract, primarily affecting the nasal mucosa, commonly known as the common cold.
| Exam domain | One-glance essentials |
|---|---|
| Definition / diagnosis |
|
| Epidemiology / risks |
|
| Core mechanism |
|
| Clinical picture |
|
| Investigations |
|
| Management |
|
| Complications |
|
| Prevention / follow-up |
|
| Exam traps |
|
References
[1] Senior notes: Ryan Ho Respiratory.pdf (p.49 — Section 3.1.1.1 Acute Coryza) [2] Senior notes: Adrian Lui Pediatrics Notes.pdf (p.154–161 — URTI spectrum, differential diagnoses table, croup) [3] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (p.119–121 — Common Cold pathogenesis and clinical manifestation) [4] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (p.137–139 — ABRS diagnostic criteria, physical examination, imaging) [5] Senior notes: Adrian Lui Pediatrics Notes.pdf (p.156 — Acute Coryza section) [6] Lecture slides: CFB WCS29_Common ENT conditions 2023.pdf (p.14–15 — Rhinosinusitis definition, predisposing factors) [7] Lecture slides: CFB WCS29_Common ENT conditions 2023.pdf (p.14–15 — Sinusitis/Rhinosinusitis definition, etiology, predisposing factors) [8] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (p.120–122 — URT vs LRT features, differential diagnosis) [9] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (p.96 — Differential diagnosis of common cold) [10] Lecture slides: GC 141. A child with cough acute and chronic cough in children.pdf (p.15 — Structured approach to acute cough) [11] Lecture slides: GC 021. Upper respiratory tract infections.pdf (p.28 — Hoarseness differential diagnosis) [12] Senior notes: Ryan Ho Respiratory.pdf (p.49 — Section 3.1.1.1 Acute Coryza, red flags) [13] Senior notes: Ryan Ho Respiratory.pdf (p.49–51 — Acute Coryza, red flags) [14] Senior notes: Adrian Lui Pediatrics Notes.pdf (p.154–161 — URTI spectrum, pertussis, croup) [15] Senior notes: Maksim Medicine Notes.pdf (p.185–187 — Pneumonia investigations, NP swab indications) [16] Senior notes: Maksim Medicine Notes.pdf (p.201–203 — COVID-19 management, antivirals) [17] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (p.113 — ABRS diagnostic criteria, imaging) [18] Senior notes: Ryan Ho Respiratory.pdf (p.51 — Centor criteria, GAS pharyngitis diagnosis) [19] Senior notes: Adrian Lui Pediatrics Notes.pdf (p.156 — Acute Coryza management, precautions, Reye syndrome) [20] Senior notes: Ryan Ho Respiratory.pdf (p.49 — Management table, symptomatic treatment evidence) [21] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (p.127–129 — Treatment, patient counselling, indications for antivirals) [22] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (p.103 — Treatment, patient counselling, high-risk groups) [23] Senior notes: Adrian Lui Pediatrics Notes.pdf (p.156 — Complications of acute coryza) [24] Lecture slides: GC 021. Upper respiratory tract infections.pdf (p.20 — Runny nose and nasal congestion: complications) [25] Lecture slides: GC 215. Common nasal conditions and nasopharyngeal carcinoma.pdf (p.22 — Complications of acute bacterial rhinosinusitis) [26] Senior notes: Ryan Ho Respiratory.pdf (p.49 — Complications of acute coryza) [27] Senior notes: Maksim Medicine Notes.pdf (p.297 — Asthma triggers including URTI/rhinovirus) [28] Lecture slides: GC 040. Cough and wheezing_asthma and allergic lung diseases.pdf [29] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (p.95–109 — Common Cold and Sinusitis)
Acute Coryza (Common Cold / Viral Upper Respiratory Infection)
Acute coryza — from Greek koryza (κόρυζα) = "running from the nose" — is the most common type of upper respiratory tract infection (URTI) [1][2]. It is a self-limiting, acute viral infection predominantly affecting the nasal mucosa and nasopharynx, often extending to involve the pharynx and larynx. Synonyms include common cold, viral URI (VURI), and nasopharyngitis.
The key concept: the symptoms you experience during a cold are overwhelmingly driven by your own immune response (innate immunity — cytokines, bradykinin, vascular leak) rather than direct viral cytopathic damage to the respiratory epithelium [3][4]. This is why immunosuppressed patients may paradoxically have milder cold symptoms — they mount a weaker inflammatory response.
Core Concept – Why Do We Get Cold Symptoms?
The cold virus itself does relatively little direct damage. Instead, infected epithelial cells release cytokines and chemokines (IL-1, IL-6, IL-8, TNF-α) that recruit polymorphonuclear leukocytes (PMNs) and cause increased vascular permeability with release of bradykinin and albumin. Bradykinin stimulates pain nerve endings (→ sore throat) and causes vasodilation and plasma extravasation (→ rhinorrhoea, nasal congestion). This is the innate immune response at work.
2. Epidemiology
- The most common infectious disease in humans [1][2]
- Adults: average 2–4 episodes/year
- Children: average 6–8 episodes/year (up to 10–12 in nursery/daycare-attending children)
- Why more frequent in children? Their immune system is naïve (first encounters with each of the > 200 viral subtypes), they have closer physical contact in schools/daycare, and they have poorer hand hygiene
- Seasonal variation: peaks in autumn and winter in temperate climates (including Hong Kong)
- Why? Indoor crowding increases droplet transmission; lower humidity may impair mucociliary clearance and stabilise some viruses; cooler nasal mucosal temperatures may favour rhinovirus replication
- Hong Kong's subtropical climate means year-round circulation of respiratory viruses, but with peaks in winter (December–February) and a smaller peak in spring/early summer
- Influenza in Hong Kong follows a bimodal seasonal pattern (winter peak + summer peak), unlike the single winter peak in temperate regions
- Post-COVID-19 pandemic awareness has heightened vigilance for respiratory symptoms; SARS-CoV-2 remains in the differential
Risk factors for increased susceptibility and severity of URTIs [3][4]:
| Risk Factor | Mechanism |
|---|---|
| Underlying chronic illness | Impaired mucosal/systemic immunity |
| Immunocompromised state | Reduced ability to clear virus; risk of secondary infections |
| Malnutrition | Protein-energy malnutrition impairs immune cell production and function |
| Smoking (active or passive) | Damages ciliated epithelium → impaired mucociliary clearance; increases mucus production; causes chronic airway inflammation |
| Psychological stress | Elevated cortisol → suppressed mucosal IgA and cellular immunity |
| Minimal/no regular exercise | Moderate exercise is immunostimulatory; sedentary behaviour is associated with higher infection rates |
| Daycare/school attendance (children) | High density of susceptible hosts + fomite contact |
| Extremes of age | Young children (naïve immunity), elderly (immunosenescence) |
| Crowded living conditions | Facilitates droplet/contact transmission |
| Allergic rhinitis / atopy | Pre-existing mucosal inflammation and oedema may impair clearance and predispose to secondary sinusitis |
4. Anatomy and Function of the Upper Respiratory Tract
Understanding where the common cold strikes requires knowing the anatomy:
- Lined by respiratory mucosa (pseudostratified ciliated columnar epithelium with goblet cells)
- Goblet cells produce mucus that traps pathogens and particles
- Cilia beat in a coordinated metachronal wave → mucociliary escalator moves mucus posteriorly towards the nasopharynx for swallowing/expectoration
- Rich submucosal vascular plexus (especially over the turbinates) — responsible for warming and humidifying inspired air; when dilated by inflammatory mediators → nasal congestion
- Nasal-associated lymphoid tissue (NALT) — immune surveillance
- Posterior to nasal cavity, above the soft palate
- Contains the pharyngeal tonsil (adenoid) — lymphoid tissue important in children's immune defence
- Eustachian tube opening — connects to the middle ear; when oedematous → Eustachian tube dysfunction → acute otitis media (this is why AOM is such a common complication in children)
- The pharyngeal mucosa contains lymphoid tissue (Waldeyer's ring: pharyngeal tonsil, tubal tonsils, palatine tonsils, lingual tonsil)
- Sore throat arises from inflammation here (pharyngitis)
- When infection extends to the larynx → laryngitis (hoarseness)
- Below the larynx → tracheobronchitis (retrosternal tightness, wheezing)
- Four pairs: maxillary, ethmoid, frontal, sphenoid [5]
- Drain via ostia into the nasal cavity (most drain into the middle meatus via the ostiomeatal complex)
- Sinusitis arises when mucosal oedema obstructs the ostia → impaired drainage → mucus stasis → secondary bacterial infection [5]
- In children < 2 years, the sinus ostia are relatively larger compared to the sinus body, making obstruction less likely — hence sinusitis is less common in very young children [4]
Why Does the Common Cold Cause Sinusitis?
Viral infection of the nasal mucosa → inflammatory oedema of the mucosa lining the sinus ostia → obstruction of sinus drainage → stasis of mucus within the sinus → impaired mucociliary clearance creates a warm, moist, stagnant environment → secondary bacterial overgrowth → acute bacterial rhinosinusitis. The same mechanism at the Eustachian tube orifice explains acute otitis media.
5. Aetiology
> 200 viral subtypes can cause the common cold [1][2]:
| Virus | Approximate % | Key Features |
|---|---|---|
| Rhinovirus | 30–50% | > 100 serotypes; optimal replication at 33°C (nasal temperature); most common cause overall |
| Coronavirus (non-SARS) | 10–15% | Seasonal; includes HCoV-229E, HCoV-OC43, HCoV-NL63, HCoV-HKU1 |
| Influenza virus | 5–15% | Types A, B; can cause severe systemic illness; distinguishable by myalgia, high fever |
| RSV (Respiratory Syncytial Virus) | ~5% | Major cause of bronchiolitis in infants; can cause wheezing in older children/adults |
| Parainfluenza virus | ~5% | Major cause of croup in children |
| Adenovirus | Variable | Pharyngoconjunctival fever; can cause severe pneumonia |
| Enterovirus | Variable | Summer-autumn predominance; can cause hand-foot-mouth disease, herpangina |
| Metapneumovirus (hMPV) | Variable | Similar clinical picture to RSV |
| SARS-CoV-2 | Variable (endemic) | Must be considered in the Hong Kong context; overlapping symptoms with common cold |
| Bocavirus | Rare | Mainly in young children |
Rhinovirus deserves special mention: it has > 100 serotypes, which is why you can catch colds repeatedly — immunity to one serotype does not protect against others. It replicates optimally at 33°C, which is the temperature of the nasal mucosa (cooler than core body temperature of 37°C). This partly explains why "catching a chill" may predispose to colds — cool air lowers nasal mucosal temperature, favouring rhinovirus replication.
Three main mechanisms; most contagious at onset of symptoms and when febrile [1][2]:
-
Hand/fomite contact (most important route for rhinovirus)
-
Droplet transmission (large droplets > 5 μm, travel < 1–2 metres)
- Generated by coughing, sneezing, talking
- Primary route for influenza
-
Aerosol (airborne) transmission (small droplet nuclei < 5 μm, can remain suspended)
- Relevant for selected viruses only (e.g., influenza, measles, SARS-CoV-2)
- Less important for rhinovirus
High Yield – Hand Hygiene
Hand-washing is the single most effective measure to prevent transmission of the common cold. This is because the predominant transmission route (especially for rhinovirus) is hand-to-hand/fomite-to-hand contact followed by self-inoculation of nasal or conjunctival mucosa. This is a favourite exam point.
6. Pathophysiology
The pathophysiology is elegantly simple and explains every single symptom:
-
Cold virus deposits on nasal or conjunctival mucosa and attaches to receptors on epithelial cells in the nasopharynx and enters the cells [3][4]
- Rhinovirus binds ICAM-1 (intercellular adhesion molecule-1) on nasal epithelial cells (major group) or LDLR (low-density lipoprotein receptor, minor group)
- Coronavirus binds ACE2 (SARS-CoV-2) or aminopeptidase N (HCoV-229E)
-
Infected cells release cytokines which attract PMNs [3][4]
- Key cytokines: IL-1, IL-6, IL-8, TNF-α
- IL-8 is a potent neutrophil chemoattractant
-
Mucociliary clearance is slow [3][4] — due to:
- Direct viral damage to some ciliated cells
- Inflammatory oedema of the mucosa
- Increased viscosity of secretions
-
Accumulation of PMNs in nasal secretions — the colour of nasal discharge correlates with PMN count and enzymatic activity [3][4]:
- White: small amount of PMNs
- Yellow: increased PMNs
- Green: increased PMNs AND PMN enzymatic activity (myeloperoxidase — a green-coloured enzyme)
High Yield – Nasal Discharge Colour
The colour of nasal discharge does NOT correlate with the necessity of antibiotic use [3][4]. Coloured (yellow/green) nasal discharge is a normal, self-limited phase of an uncomplicated common cold. Purulence alone cannot distinguish between a cold and a sinus infection. This is one of the most common mistakes — parents and even some clinicians mistakenly believe green snot = bacterial infection requiring antibiotics. It doesn't.
-
Increased vascular permeability and release of albumin and bradykinin [3][4]
-
Parasympathetic reflex activation:
- Nasal irritation → sneezing reflex (trigeminal afferent → sneeze centre in medulla → efferent motor response)
- Parasympathetic stimulation → serous gland hypersecretion → watery rhinorrhoea
- Cough usually appears after onset of rhinorrhoea/nasal obstruction [1][2][3]
- Post-nasal drip: mucus drips posteriorly from the nasopharynx onto the pharyngeal/laryngeal mucosa → stimulates cough receptors
- Direct inflammation of pharyngeal/laryngeal mucosa
- Post-viral cough: commonly persists past the time nasal and throat symptoms resolve [1][2] — due to residual airway hyperreactivity and inflammation of the cough receptor nerves (transient receptor potential channels remain sensitised)
7. Classification
Acute coryza is classified within the broader framework of URTIs:
| Condition | Primary Site | Key Feature |
|---|---|---|
| Acute coryza / Nasopharyngitis | Nasal cavity + nasopharynx | Rhinorrhoea, congestion, sneezing |
| Pharyngitis | Oropharynx | Sore throat predominant |
| Tonsillitis | Palatine tonsils | Exudate, odynophagia |
| Laryngitis | Larynx | Hoarseness |
| Tracheobronchitis | Trachea + bronchi | Retrosternal pain, cough |
| Rhinosinusitis | Nasal cavity + paranasal sinuses | Facial pain/pressure, purulent discharge |
| Acute otitis media | Middle ear | Otalgia, bulging TM |
| Epiglottitis | Epiglottis | Emergency — stridor, drooling |
| Croup (Laryngotracheobronchitis) | Subglottic larynx + trachea | Barking cough, inspiratory stridor |
8. Clinical Features
| Symptom | Pathophysiological Basis |
|---|---|
| Rhinorrhoea (nasal discharge) | Bradykinin-mediated vascular permeability → plasma exudation; parasympathetic-driven serous gland secretion; PMN accumulation |
| Nasal congestion / blocked nose | Vasodilation of submucosal venous sinusoids (turbinates) by bradykinin, histamine, and prostaglandins → mucosal swelling → obstruction of nasal airway |
| Sneezing | Trigeminal nerve stimulation by inflammatory mediators → sneeze reflex arc (medullary sneeze centre) |
| Sore throat (pharyngitis) — dry and scratchy | Bradykinin stimulates pain nerve endings in pharyngeal mucosa; mucosal inflammation and oedema |
| Cough — often appears after onset of nasal discharge and obstruction | Post-nasal drip irritating laryngeal/pharyngeal cough receptors; direct inflammation of lower pharynx/larynx; airway hyperreactivity |
| Post-viral cough | Persistent sensitisation of transient receptor potential (TRP) channels on vagal afferent C-fibres after resolution of acute inflammation |
| Low-grade fever ± chills and rigors | Cytokines (IL-1, IL-6, TNF-α, PGE₂) act on hypothalamic thermoregulatory centre → raise the temperature set-point; may be predominant manifestation in young children; uncommon in older children and adults [3][4] |
| Malaise / Fatigue | Circulating IL-1 and TNF-α → sickness behaviour (central effect on brain) |
| Headache | Referred pain from inflamed sinus mucosa (even without true sinusitis); systemic cytokine effects |
| Hoarseness | Laryngeal mucosal inflammation → vocal cord oedema → altered vibration |
| Retrosternal chest tightness / wheezing | Extension of inflammation to trachea/bronchi (tracheobronchitis); especially with RSV and parainfluenza [1][2]; may trigger bronchospasm in those with asthma or airway hyperreactivity |
| Otalgia / Ear pulling (especially children) | Eustachian tube mucosal oedema → negative middle ear pressure → otalgia; or early AOM |
| Red eye (conjunctival injection) | Direct viral inoculation of conjunctival mucosa or reflex lacrimation and hyperaemia |
| Anorexia / Decreased oral intake | Cytokine-mediated appetite suppression; difficulty feeding (nasal obstruction in infants who are obligate nasal breathers) |
| Irritability (children) | General malaise, otalgia, nasal obstruction; inability to communicate discomfort |
| Post-tussive vomiting | Violent coughing → raised intra-abdominal pressure → vomiting reflex |
High Yield – Fever in the Common Cold
New onset or recurrence of fever after initial improvement may suggest secondary bacterial infection [3][4]. A common clinical pearl: if a child with a cold improves over days 3–5 and then develops new fever on day 6–7 with worsening symptoms, think about secondary acute bacterial rhinosinusitis or acute otitis media.
| Sign | Pathophysiological Basis |
|---|---|
| Nasal mucosal erythema and oedema (on anterior rhinoscopy) | Inflammatory vasodilation and plasma exudation |
| Nasal discharge — initially clear/watery → may become mucopurulent | Serous fluid → PMN infiltration changes colour (white → yellow → green); colour does NOT indicate bacterial infection [3][4] |
| Pharyngeal erythema (injected pharynx) | Mucosal inflammation from direct viral infection or post-nasal drip |
| Mild cervical lymphadenopathy (especially anterior cervical chain) | Reactive lymphoid hyperplasia draining the nasopharyngeal lymphatics |
| Low-grade pyrexia (often < 38.5°C in adults; may be higher in young children) | Cytokine-driven hypothalamic set-point elevation |
| Conjunctival injection | Direct viral inflammation or reflex hyperaemia |
| Mildly erythematous tympanic membranes | Eustachian tube dysfunction → mild serous effusion; or early AOM |
| Cobblestoning of posterior pharyngeal wall | Lymphoid follicular hyperplasia from chronic post-nasal drip stimulation |
| Absence of focal lower respiratory signs | Distinguishes uncomplicated URTI from pneumonia — no crackles, bronchial breathing, or signs of consolidation |
The following should raise alarm for an alternative or complicating diagnosis:
- High persistent fever (> 39°C) for > 3 days
- Severe systemic toxicity
- Unilateral facial pain/swelling (sinusitis complication)
- Stridor (croup, epiglottitis)
- Significant respiratory distress / tachypnoea / hypoxia
- Focal chest signs (consolidation → pneumonia)
- Drooling with dysphagia (epiglottitis)
Red flags that may indicate other serious pathologies [1][2]:
| Condition | Red Flag Features | Why? |
|---|---|---|
| Acute Otitis Media | Otalgia, otorrhoea, hearing loss, dizziness | Eustachian tube dysfunction → middle ear effusion → bacterial superinfection |
| Pneumonia / Bronchitis | Deep cough/mucus, pleuritic chest pain, wheezes, mild SOB, chest tightness | Extension of infection to lower respiratory tract |
| Epiglottitis | Alteration in voice, severe sore throat with dysphagia, stridor, drooling | Inflammation of the epiglottis → airway compromise; MEDICAL EMERGENCY |
| Croup (Laryngotracheobronchitis) | Hoarseness, barky seal cough or persistent hacky cough, inspiratory stridor | Subglottic oedema narrowing the airway |
| Pertussis | Cough spasms, vomiting with cough, no fever | Bordetella pertussis toxin causes paroxysmal cough without typical inflammatory fever |
| Acute bacterial rhinosinusitis | Persistent symptoms > 10 days without improvement, or "double worsening" (improvement then deterioration), high fever ≥ 39°C with purulent discharge for ≥ 3 consecutive days | Secondary bacterial infection of obstructed sinuses |
| Meningitis | Neck stiffness, photophobia, altered consciousness, non-blanching rash | Rare but must not be missed; some viruses (enterovirus) can cause meningitis |
10. Relationship Between Acute Coryza and Other Conditions
- Asthma exacerbation may be triggered by URTI (rhinovirus is the most common trigger) [6][7]
- Mechanism: viral infection causes epithelial damage and release of pro-inflammatory mediators (IL-25, IL-33, TSLP) → amplification of type 2 inflammation → eosinophilic airway inflammation + airway hyperreactivity → bronchoconstriction
- RSV and parainfluenza may cause wheezing → prompt investigation for asthma if persistent [1][2]
| Feature | Acute Coryza (Viral) | Allergic Rhinitis |
|---|---|---|
| Onset | Gradual over hours | Rapid after allergen exposure |
| Duration | 7–10 days, self-limiting | Chronic/recurrent, linked to allergen exposure |
| Nasal discharge | Initially watery → mucopurulent | Persistently watery, clear |
| Itch | Minimal | Prominent (nasal, ocular, palatal) |
| Sneezing | Present | Present (often in paroxysms) |
| Fever | May have low-grade | Absent |
| Conjunctivitis | Mild | Often prominent (allergic conjunctivitis) |
| Seasonality | Autumn/winter peaks | Seasonal (pollen) or perennial (dust mite) |
| Family/personal history of atopy | Not specifically | Strongly associated |
- Predisposing factors for rhinosinusitis [5]:
- Anatomical: deviated septum, nasal polyp, tumour
- Dental root infection
- Upper respiratory tract infection
- Congenital anomalies
- Rhinosinusitis definition in adults (EPOS 2020): inflammation of the nose and paranasal sinuses characterised by ≥ 2 symptoms, one of which should be either nasal blockage/obstruction/congestion or nasal discharge (anterior/posterior nasal drip), ± facial pain/pressure, ± reduction or loss of smell [5]
11. Special Considerations in Hong Kong
- Rhinovirus circulates year-round but peaks in autumn and spring
- Influenza has a bimodal pattern (January–March and July–August)
- RSV peaks in spring–summer (March–July) in Hong Kong — opposite to temperate regions
- Acute coryza symptoms overlap significantly with mild COVID-19
- Rapid antigen testing (RAT) or PCR may still be indicated in certain clinical settings (e.g., hospital admissions, elderly homes)
- Hong Kong has an ongoing antimicrobial stewardship programme
- A major public health message: antibiotics are NOT indicated for acute coryza — this is a viral illness
- Inappropriate antibiotic prescribing for URTI remains a significant issue globally and locally
High Yield Summary
Acute Coryza (Common Cold):
- Most common infectious disease in humans; caused by > 200 viral subtypes, predominantly rhinovirus (30–50%)
- Symptoms are caused by the innate immune response (cytokines, bradykinin, PMN infiltration), not direct viral damage
- Colour of nasal discharge does NOT indicate bacterial infection — green/yellow = PMN enzymatic activity (myeloperoxidase), NOT bacteria
- Typical course: 24–72h incubation → peak day 2–3 → resolution in 7–10 days (up to 14 days)
- Hand-washing is the single most effective prevention measure
- Antibiotics are NOT indicated — this is a self-limiting viral illness
- Red flags for complications: new/recurrent fever after improvement (secondary bacterial infection), stridor (croup/epiglottitis), respiratory distress (pneumonia), severe otalgia (AOM)
- Common complications: acute rhinosinusitis, AOM (especially children), asthma exacerbation, lower respiratory tract involvement
- Rhinovirus is the most common trigger for asthma exacerbation
- Distinguish from allergic rhinitis (prominent itch, clear watery discharge, no fever, atopic history)
Active Recall - Acute Coryza (Part 1: Definition to Clinical Features)
[1] Senior notes: Adrian Lui Pediatrics Notes.pdf (p.156 — Acute Coryza section) [2] Senior notes: Ryan Ho Respiratory.pdf (p.49 — Section 3.1.1.1 Acute Coryza) [3] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (p.119–121 — Common Cold pathogenesis and clinical manifestation) [4] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (p.95–109 — Common Cold and Sinusitis) [5] Lecture slides: CFB WCS29_Common ENT conditions 2023.pdf (p.14–15 — Sinusitis/Rhinosinusitis definition, etiology, predisposing factors) [6] Senior notes: Maksim Medicine Notes.pdf (p.297 — Asthma triggers including URTI/rhinovirus) [7] Lecture slides: GC 040. Cough and wheezing_asthma and allergic lung diseases.pdf
Differential Diagnosis of Acute Coryza
The differential diagnosis of acute coryza is really the differential of a patient presenting with acute-onset nasal symptoms (rhinorrhoea, congestion, sneezing) ± sore throat ± cough ± low-grade fever. Your job is to distinguish the benign, self-limiting common cold from conditions that either mimic it or complicate it. The approach is systematic — think anatomically (upper vs. lower respiratory tract), aetiologically (viral vs. bacterial vs. allergic vs. other), and by severity (benign vs. red-flag).
1. Framework for Differential Diagnosis
This is your first branch point. If the symptoms are confined to the upper airway, you are dealing with a URTI or its mimic. If lower tract features are present, you must consider pneumonia, bronchiolitis, or asthma.
URT signs and symptoms (more ENT symptoms) [3][4]:
- Stridor
- Red eyes
- Runny nose
- Sore throat
- Hoarseness
- Ear pain — look for reaching out to ears or ear pulling in children [3][4]
LRT signs and symptoms [3][4]:
- Wheezing
- Cyanosis
- Shortness of breath (SOB)
- Pleuritic chest pain
Why this matters: If a child or adult presents with what looks like a cold but has tachypnoea, chest indrawing, crepitations, or wheeze, the disease has either extended to the lower respiratory tract or was never just a cold in the first place. This distinction drives your investigations and management.
The GC 141 lecture provides a structured diagnostic approach that is extremely high-yield for in-house exams [8]:
High Yield – GC 141 Approach to Acute Cough
Approach to try to arrive at a specific diagnosis for acute cough [8]:
| Question | Features | Likely Common Dx |
|---|---|---|
| Is this an acute URI? | Coryzal symptoms, fever, sore throat | URI |
| Is this a croup syndrome? | Stridor, "barking" or "croupy cough", hoarseness, ± fever | Viral croup, recurrent spasmodic croup, bacterial tracheitis |
| Is this a lower respiratory tract illness? | Tachypnoea ( > 60 for < 2m, > 50 for 2–12m, > 40 for > 1yr), respiratory distress with increased work of breathing, chest signs (crepitations or wheeze/rhonchi), fever | Acute bronchiolitis, pneumonia (viral, bacterial), asthma |
| Is this an allergic/atopic illness? | Seasonal and diurnal variation, association with rhinitis, posture, "clearing of throat", triggers (dust, pollutant, pollen etc.) | Post-nasal drip from allergic rhinitis, reactive airway/asthma |
| Is this an acute exacerbation of a chronic respiratory disorder? | Failure to thrive, finger clubbing, chest deformity, features of atopy | (continued — e.g., cystic fibrosis, bronchiectasis) |
3. Key Differential Diagnoses — Detailed Comparison
3.1 Infectious Differentials
More severe illness such as abrupt onset of fever, headache, myalgia and malaise [3][4]
| Feature | Acute Coryza | Influenza |
|---|---|---|
| Onset | Gradual (over 1–2 days) | Abrupt (within hours) |
| Fever | Low-grade or absent (especially adults) | High fever (up to 39–40°C), prominent |
| Myalgia/arthralgia | Mild or absent | Prominent — severe body aches |
| Headache | Mild | Prominent |
| Nasal symptoms | Predominant | Present but less prominent |
| Sore throat | Dry/scratchy | Can be present |
| Cough | After nasal symptoms | Can be severe, dry |
| GI symptoms | Absent | Possible (especially influenza B in children) |
| Duration | 7–10 days | 7–14 days; prolonged fatigue |
| Systemic toxicity | Mild | Significant |
| Complications | Sinusitis, AOM | Pneumonia (primary viral or secondary bacterial), myocarditis, encephalitis |
Why the distinction matters: Influenza has specific antiviral treatment (oseltamivir/zanamivir, most effective if started within 48 hours of symptom onset) and carries a much higher risk of serious complications, especially in the elderly, pregnant women, young children, and immunocompromised patients [1].
GAS tonsillopharyngitis is usually not accompanied by nasal symptoms [3][4]
This is a critical distinguishing point: the common cold is a nasal-predominant illness, whereas streptococcal pharyngitis is a throat-predominant illness with minimal nasal symptoms.
| Feature | Acute Coryza | GAS Pharyngitis |
|---|---|---|
| Nasal symptoms | Prominent (rhinorrhoea, congestion) | Absent or minimal |
| Cough | Common | Typically absent |
| Hoarseness | May occur | Typically absent |
| Sore throat | Dry, scratchy | Severe, sudden onset |
| Tonsillar exudate | Absent | Present — white/yellow patches |
| Cervical lymphadenopathy | Mild, diffuse | Tender anterior cervical LAP |
| Fever | Low-grade | High (often > 38.5°C) |
| Headache / abdominal pain | Unusual | Can occur, especially in children |
| Palatal petechiae | Absent | Suggestive of GAS |
| Scarlatiniform rash | Absent | Sandpaper rash → scarlet fever |
Suggestive features from Adrian Lui notes [1]: previous close exposure to strep throat, sudden onset sore throat with little viral symptoms (rhinorrhea, cough, hoarseness), exudative tonsillitis, tender anterior cervical LNs, fever, ± headache and abdominal pain
Why it matters: GAS pharyngitis requires antibiotics (penicillin V or amoxicillin) to prevent rheumatic fever (still relevant in Hong Kong and endemic regions) and peritonsillar abscess. The common cold does not need antibiotics.
The Centor criteria (modified McIsaac) help estimate the probability of GAS pharyngitis: fever > 38°C, tonsillar exudate, tender anterior cervical LAP, absence of cough. Each criterion scores 1 point. Absence of cough is a "negative" finding that actually supports GAS — because cough suggests viral URTI, not bacterial pharyngitis.
Pertussis classically begins with mild cough and coryza but the cough gradually increases and becomes paroxysmal [3][4]
| Phase | Duration | Features |
|---|---|---|
| Catarrhal phase | ~1 week | Coryzal symptoms — looks just like a common cold; most contagious period |
| Paroxysmal phase | ~3 months | Protracted whooping cough (short expiratory bursts followed by inspiratory gasp/whoop), post-tussive vomiting, no fever |
| Convalescent phase | Weeks–months | Gradual recovery |
Key distinguishing features [1]: cough spasms, vomiting with cough, no fever
Why pertussis can fool you: The catarrhal phase is essentially indistinguishable from acute coryza. The clue comes when the cough doesn't improve after 7–10 days and instead escalates into paroxysms. In adolescents/adults with waning vaccine immunity, the presentation may be atypical — just a prolonged cough without the classic whoop.
Diagnosis: nasopharyngeal swab for culture or PCR [1].
Differentiated from common cold by persistence, increased severity or worsening of symptoms [3][4]
Prolonged ( > 10–14d) URI symptoms + ≥ 2 of facial/sinus pain (especially if aggravated by postural changes or Valsalva's manoeuvre), purulent nasal discharge, fever [1]
Three clinical patterns suggest bacterial superinfection rather than a simple viral cold:
- Persistent symptoms ≥ 10 days without improvement
- "Double worsening" — initial improvement followed by new/worsening symptoms (new fever, worsening nasal discharge)
- Severe onset — high fever ≥ 39°C with purulent nasal discharge for ≥ 3 consecutive days
Why sinusitis complicates acute coryza: Viral infection → mucosal oedema → ostial obstruction → mucus stasis → secondary bacterial overgrowth (S. pneumoniae, H. influenzae, M. catarrhalis) [5].
Stridor, "barking" or "croupy cough", hoarseness, ± fever [8]
| Feature | Acute Coryza | Croup |
|---|---|---|
| Age | Any age | Typically 6 months – 6 years (peak at 2 years) [1] |
| Season | Autumn/winter | Most common in autumn [1] |
| Microbiology | Rhinovirus predominantly | Parainfluenza virus, rhinovirus, RSV, influenza [1] |
| Cough | Non-specific | Barking, seal-like cough |
| Stridor | Absent | Inspiratory stridor — worse at night |
| Hoarseness | May occur | Prominent |
| Preceding coryzal symptoms | Present | Present (differentiates from spasmodic croup which has NO preceding coryzal symptoms) [1] |
Why is the cough barking? Subglottic oedema narrows the airway just below the vocal cords → turbulent airflow through this narrowed segment produces the characteristic harsh, barking quality. Inspiratory stridor occurs because the extrathoracic trachea tends to collapse further during inspiration (negative intraluminal pressure), worsening the obstruction.
Alteration in voice, severe sore throat with dysphagia, stridor, drooling [1][2]
This is a medical emergency. The epiglottis swells to obstruct the airway.
| Feature | Acute Coryza | Epiglottitis |
|---|---|---|
| Onset | Gradual | Rapid (hours) |
| Systemic toxicity | Mild | High fever, toxic-appearing |
| Voice | Normal or mildly hoarse | "Hot potato" / muffled voice |
| Drooling | Absent | Present (unable to swallow secretions) |
| Posture | Normal | Tripod position (leaning forward, chin up) |
| Cough | Present | Absent or minimal (child avoids coughing — it hurts) |
| Stridor | Absent | Late finding — ominous sign of near-complete obstruction |
Cause: Historically Haemophilus influenzae type b (Hib) — now rare in vaccinated populations. In Hong Kong, Hib vaccine is part of the Childhood Immunisation Programme. Adult cases are more often caused by S. aureus, S. pneumoniae, or S. pyogenes.
High Yield – GC 021 Hoarseness DDx
In the current Hong Kong context, SARS-CoV-2 must always be considered when a patient presents with acute coryza symptoms. Omicron and subsequent subvariants tend to cause upper-airway-predominant symptoms (sore throat, rhinorrhoea, congestion) that are clinically indistinguishable from the common cold. Distinguishing features (when present) include anosmia/ageusia (less common with newer variants), more significant fatigue, and exposure history. Rapid antigen testing clarifies the diagnosis.
3.2 Non-Infectious Differentials
Allergic, seasonal or vasomotor rhinitis [3][4]
| Feature | Acute Coryza | Allergic Rhinitis |
|---|---|---|
| Onset | Gradual over hours | Rapid after allergen exposure |
| Duration | 7–10 days, self-limiting | Chronic/recurrent; linked to allergen exposure |
| Nasal discharge | Initially watery → mucopurulent | Persistently clear and watery |
| Itch | Minimal | Prominent — nasal, ocular, palatal |
| Sneezing | Present | Paroxysmal (repeated volleys) |
| Fever | May have low-grade | Absent |
| Conjunctivitis | Mild | Prominent (allergic conjunctivitis — bilateral, watery, itchy) |
| "Allergic salute" | Absent | Upward rubbing of nose |
| "Allergic shiners" | Absent | Infraorbital dark circles (venous congestion) |
| Pale, boggy turbinates | No (erythematous) | Yes — on anterior rhinoscopy |
| Personal/family atopy | Not specifically | Strongly associated (eczema, asthma triad) |
Why allergic rhinitis mimics a cold: Both involve nasal mucosal oedema and rhinorrhoea. However, in allergic rhinitis the mechanism is IgE-mediated mast cell degranulation (Type I hypersensitivity) rather than viral cytokine release. Mast cell mediators (histamine, leukotrienes) cause the same downstream effects (vasodilation, increased vascular permeability, mucus secretion, nerve stimulation) but with prominent itch (histamine acting on H₁ receptors on sensory nerves) — itch is the distinguishing symptom.
- Chronic rhinorrhoea and congestion triggered by temperature changes, strong odours, humidity, smoke, spicy food
- No itch, no atopic associations, no fever
- Mechanism: autonomic nervous system dysregulation of nasal vasculature → excessive parasympathetic-driven secretion and vasodilation
- Typically perennial rather than seasonal
In a young child with unilateral, foul-smelling, purulent (± blood-stained) nasal discharge — think foreign body. Acute coryza causes bilateral symptoms. A unilateral presentation should always trigger consideration of a foreign body, especially in children aged 2–5 years.
Anatomical predisposing factors: deviated septum, polyp, tumour [5]
- Nasal polyps — chronic unilateral or bilateral nasal obstruction and hyposmia; associated with aspirin-exacerbated respiratory disease (Samter's triad: asthma + nasal polyps + aspirin sensitivity)
- Nasopharyngeal carcinoma (NPC) — important in Hong Kong (high prevalence in Southern Chinese). Presents with unilateral nasal obstruction, blood-stained post-nasal drip, unilateral serous otitis media, and cervical lymphadenopathy. Must be considered in any adult with persistent unilateral nasal symptoms.
- Adenoid hypertrophy — chronic nasal obstruction, mouth breathing, snoring in children; can be confused with chronic/recurrent colds
3.3 Lower Respiratory Tract Differentials (When LRT Features Are Present)
- Acute bronchiolitis [8] — common in infants < 2 years (peak 2–6 months)
- Usually caused by RSV
- Starts with coryzal symptoms then progresses to tachypnoea, subcostal/intercostal recession, fine crackles, wheeze, feeding difficulty
- Distinguished from a cold by respiratory distress and lower airway signs
- Pneumonia [8] — tachypnoea, fever, crepitations, bronchial breathing, chest indrawing
- Can follow a viral URTI (secondary bacterial pneumonia)
- CXR shows consolidation
- Reactive airway/asthma [8] — triggered by URTI (rhinovirus is #1 trigger)
- Seasonal and diurnal variation, association with rhinitis, posture, "clearing of throat", triggers [8]
- Wheeze, cough (especially nocturnal), chest tightness; responds to bronchodilators
- In a child presenting with a "cold" that progresses to persistent wheezing, always investigate for asthma
- Extension of URTI to the tracheobronchial tree
- Retrosternal chest tightness, productive cough, low-grade fever
- No focal consolidation on examination or CXR (differentiates from pneumonia)
| Condition | Key Distinguishing Features vs. Acute Coryza |
|---|---|
| Influenza | Abrupt onset, high fever, severe myalgia, systemic toxicity |
| GAS Pharyngitis | Severe sore throat, tonsillar exudate, no nasal symptoms, tender anterior cervical LAP |
| Pertussis | Catarrhal phase mimics cold → paroxysmal cough with whoop, post-tussive vomiting, no fever |
| Acute Bacterial Rhinosinusitis | Symptoms > 10 days without improvement, double worsening, facial pain |
| Croup | Barking cough, inspiratory stridor, hoarseness; age 6m–6y |
| Epiglottitis | Rapid onset, toxic, drooling, muffled voice, dysphagia — EMERGENCY |
| COVID-19 | Clinically overlapping; anosmia/ageusia (less common now); RAT/PCR confirms |
| Allergic Rhinitis | Prominent itch (nasal, ocular, palatal), clear watery discharge, no fever, atopic hx |
| Vasomotor Rhinitis | Triggered by temperature/odours, no itch, no atopy, no fever, chronic |
| Foreign Body | Unilateral foul-smelling purulent ± blood-stained discharge (child) |
| NPC | Unilateral nasal obstruction, blood-stained post-nasal drip, unilateral SOM, cervical LAP (HK!) |
| Bronchiolitis | Infant < 2y, RSV, tachypnoea, recession, fine crackles, feeding difficulty |
| Pneumonia | Tachypnoea, high fever, crackles/bronchial breathing, CXR consolidation |
| Asthma | Wheeze, nocturnal cough, diurnal variation, triggers, reversible obstruction |
When a patient presents with "cold" symptoms, ask yourself these questions in sequence:
- Is this really an upper respiratory problem? → Check for tachypnoea, chest signs, oxygen saturation → if present, think lower tract
- Is there stridor? → Croup vs. epiglottitis (urgency!)
- Is there severe sore throat without nasal symptoms? → GAS pharyngitis / peritonsillar abscess
- Is there prominent itch and clear watery discharge? → Allergic rhinitis
- Has the cough become paroxysmal without fever? → Pertussis
- Have symptoms persisted > 10 days or double-worsened? → Bacterial rhinosinusitis
- Is the nasal discharge unilateral and foul? → Foreign body (child) or NPC (adult in Hong Kong)
- Is there abrupt onset with myalgia, high fever? → Influenza → consider RAT/PCR, antivirals
High Yield – DDx Exam Approach
For exams, always structure your differential diagnosis by asking: (1) Upper vs. lower tract? (2) Infectious vs. non-infectious? (3) Viral vs. bacterial? (4) Are there any red flags? This systematic approach ensures you don't miss dangerous diagnoses while correctly identifying the most common one — acute coryza.
High Yield Summary – Differential Diagnosis of Acute Coryza
- Most important differentials: Influenza (systemic toxicity, myalgia), GAS pharyngitis (no nasal symptoms, tonsillar exudate), pertussis (paroxysmal cough, no fever), acute bacterial rhinosinusitis (symptoms > 10 days or double worsening), croup (barking cough, stridor), epiglottitis (EMERGENCY — drooling, dysphagia, stridor)
- Non-infectious mimics: Allergic rhinitis (itch, clear discharge, atopy), vasomotor rhinitis, foreign body (unilateral), NPC (Hong Kong — unilateral, blood-stained)
- Lower tract extension: Bronchiolitis (infants, RSV), pneumonia, asthma exacerbation
- GAS pharyngitis is NOT accompanied by nasal symptoms — this is the key distinguishing feature from viral URTI
- Colour of nasal discharge does NOT indicate bacterial infection — do not start antibiotics for green snot alone
- COVID-19 must be considered in the current era; RAT/PCR differentiates
- Use the GC 141 structured approach for paediatric acute cough differentials
Active Recall - Differential Diagnosis of Acute Coryza
References
[1] Senior notes: Adrian Lui Pediatrics Notes.pdf (p.154–161 — URTI spectrum, differential diagnoses table, croup) [2] Senior notes: Ryan Ho Respiratory.pdf (p.49 — Section 3.1.1.1 Acute Coryza, red flags) [3] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (p.120–122 — URT vs LRT features, differential diagnosis) [4] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (p.96 — Differential diagnosis of common cold) [5] Lecture slides: CFB WCS29_Common ENT conditions 2023.pdf (p.14–15 — Rhinosinusitis definition, predisposing factors) [8] Lecture slides: GC 141. A child with cough acute and chronic cough in children.pdf (p.15 — Structured approach to acute cough) [9] Lecture slides: GC 021. Upper respiratory tract infections.pdf (p.28 — Hoarseness differential diagnosis)
Diagnostic Criteria, Diagnostic Algorithm, and Investigations for Acute Coryza
1. Diagnostic Criteria
Acute coryza is fundamentally a clinical diagnosis. There are no formal diagnostic criteria in the way that, say, rheumatic fever has Jones criteria. Instead, you diagnose the common cold by recognising the characteristic symptom pattern, typical timeline, and absence of features suggesting an alternative or more serious diagnosis.
The diagnosis rests on:
- Acute onset of predominantly nasal symptoms (rhinorrhoea, nasal congestion, sneezing)
- ± sore throat (dry, scratchy), ± cough (typically appearing after nasal symptoms)
- ± low-grade fever (more common in children)
- ± malaise, headache
- Self-limiting course: symptoms peak at day 2–3, resolve within 7–10 days (up to 14 days in some) [1][2]
- Absence of red-flag features (stridor, significant respiratory distress, high persistent fever, focal chest signs, severe systemic toxicity)
Why no specific diagnostic test? Because (a) > 200 viral subtypes cause the same syndrome — testing for each is impractical and changes nothing in management, (b) the illness is self-limiting and benign, and (c) treatment is purely supportive regardless of the specific virus. Investigations are only warranted to exclude alternative diagnoses or detect complications.
High Yield – When Is Acute Coryza NOT the Diagnosis?
The real clinical skill is knowing when the presentation is not just a common cold. You should suspect an alternative diagnosis when:
- Symptoms persist ≥ 10 days without improvement → bacterial rhinosinusitis
- "Double worsening" (improvement then deterioration after day 5–6) → bacterial rhinosinusitis
- High fever ≥ 39°C with purulent discharge for ≥ 3 days from onset → bacterial rhinosinusitis
- Stridor, barking cough → croup or epiglottitis
- Paroxysmal cough escalating beyond 10 days → pertussis
- Severe sore throat without nasal symptoms → GAS pharyngitis
- Tachypnoea, chest signs, respiratory distress → lower respiratory tract infection
1.2 Diagnostic Criteria for Key Complications / Differentials (For Comparison)
Understanding the criteria for the conditions you must distinguish from acute coryza is essential:
High Yield – ABRS Diagnostic Criteria
Acute bacterial rhinosinusitis is diagnosed clinically when ANY ONE of the following patterns is present [3][4]:
- Persistent symptoms or signs of ARS lasting ≥ 10 days without evidence of clinical improvement
- Onset of severe symptoms or signs of high fever and purulent nasal discharge or facial pain for at least 3–4 consecutive days at the beginning of illness
- Symptoms of a typical viral URTI that are slowly improving but worsen again with more severe symptoms and signs after 5–6 days ("double worsening")
Acute viral rhinosinusitis: symptoms < 10 days and NOT worsening [3][4]
| Criterion | Points |
|---|---|
| History of fever | 1 |
| Tonsillar exudates | 1 |
| Tender anterior cervical adenopathy | 1 |
| Absence of cough | 1 |
| Age < 15 years | +1 |
| Age > 44 years | −1 |
Score interpretation [10]:
- −1 to 1 points (risk of strep throat < 10%) → no antibiotics or throat culture necessary
- 2 to 3 points (risk 15–32%) → antibiotics if throat culture positive
- 4 to 5 points (risk ~56%) → treat empirically with antibiotics
The key insight: absence of cough is a Centor criterion that supports GAS pharyngitis. If the patient has prominent cough and nasal symptoms, the probability of GAS drops sharply — this is more likely viral URTI/acute coryza.
The algorithm below encodes the clinical reasoning pathway from presentation to diagnosis:
3. Investigation Modalities
This is perhaps the most important point for both clinical practice and exams:
Uncomplicated acute coryza in an otherwise healthy patient requires NO laboratory tests, NO imaging, and NO microbiological investigations. Investigations are only indicated when you suspect a complication, an alternative diagnosis, or when the patient has risk factors for serious illness (immunocompromised, extremes of age, prolonged/atypical course).
The rationale is simple:
- Identifying the specific virus does not change management (treatment is symptomatic regardless)
- Blood tests will show non-specific changes (mild leukocytosis, elevated CRP) that do not alter the plan
- Imaging in an uncomplicated cold is a waste of resources and (in children) unnecessary radiation exposure
Investigations become important when you suspect the diagnosis is not acute coryza, or when complications arise.
| Indication | Rationale | Investigations |
|---|---|---|
| Symptoms ≥ 10 days / double worsening / severe onset | Rule out ABRS | Physical examination ± imaging |
| High fever + systemic toxicity / influenza-like illness | Confirm influenza / COVID-19; guide antiviral therapy | Rapid antigen test, NP swab PCR |
| Severe sore throat without nasal symptoms | Rule in/out GAS pharyngitis | Centor criteria ± rapid strep test ± throat culture |
| Tachypnoea, chest signs, hypoxia | Rule out pneumonia / bronchiolitis | CXR, SpO₂, bloods |
| Stridor (especially with toxic appearance) | Differentiate croup from epiglottitis | Clinical assessment ± lateral neck XR (with caution) |
| Paroxysmal cough > 2 weeks | Rule out pertussis | NP swab for culture / PCR |
| Immunocompromised patient | Higher risk of complications, atypical organisms | Lower threshold for bloods, cultures, imaging |
| Prolonged/recurrent symptoms | Rule out allergic rhinitis, foreign body, NPC | Allergy testing, nasal endoscopy, imaging |
3.3 Specific Investigation Modalities
| Test | When to Order | Key Findings / Interpretation |
|---|---|---|
| Rapid Antigen Test for Influenza | Influenza-like illness (high fever, myalgia, abrupt onset), especially during influenza season | Positive → confirms influenza; guides oseltamivir use. Sensitivity ~60–70% (can miss); if high clinical suspicion and negative RAT, send NP swab PCR |
| SARS-CoV-2 RAT / RT-PCR | Any acute respiratory symptoms in current endemic context (especially Hong Kong); hospital admission screening | Positive → isolation, contact tracing (if applicable), supportive care ± antivirals in high-risk |
| NP aspirate / swab for respiratory virus panel | Hospitalised patients, immunocompromised, epidemic investigation | Panel includes: seasonal influenza, RSV, parainfluenza, adenovirus, SARS-CoV-2, and atypicals (e.g., Mycoplasma) [6]. Positive result guides infection control and specific treatment |
| Rapid Strep Test (Rapid Antigen Detection Test — RADT) | Suspected GAS pharyngitis (Centor score ≥ 2) | Positive → treat with antibiotics. Specificity ~95%, sensitivity ~70–90%; if negative but high suspicion, follow up with throat culture [10] |
| Throat swab for culture | Negative RADT with high clinical suspicion for GAS; or in populations where rheumatic fever is a concern | Gold standard for GAS; takes 24–48 hours |
| NP swab for Bordetella pertussis PCR / culture | Paroxysmal cough > 2 weeks, post-tussive vomiting, inspiratory whoop, especially in under-vaccinated | PCR is more sensitive than culture (which requires special media — Bordet-Gengou or Regan-Lowe); culture is gold standard but takes 7–10 days [1] |
Why do we use NP aspirate/swab rather than a throat swab for respiratory viruses? The nasopharynx is the primary site of viral replication for most respiratory viruses. The viral load is highest here, giving the best diagnostic yield. Throat swabs have lower sensitivity for viruses like influenza and RSV.
Blood tests are not indicated for uncomplicated acute coryza. They become relevant when considering complications or alternative diagnoses:
| Test | When Indicated | Key Findings / Interpretation |
|---|---|---|
| Complete Blood Count with Differential Count (CBC D/C) | Suspected bacterial complication, prolonged fever, immunocompromised | Viral URTI: normal or mild lymphocytosis. Bacterial infection: neutrophilia with left shift. Pertussis: characteristic marked lymphocytosis (can be > 20 × 10⁹/L, sometimes > 50 × 10⁹/L in infants — white blood cells are predominantly mature lymphocytes). EBV (infectious mononucleosis): atypical lymphocytes |
| C-Reactive Protein (CRP) / ESR | Differentiating viral from bacterial infection; monitoring disease severity | Mild elevation in viral URTI. Markedly elevated CRP ( > 100 mg/L) suggests bacterial infection (e.g., pneumonia, bacterial sinusitis). Important caveat: CRP alone cannot confirm or exclude bacterial infection — it must be interpreted in clinical context |
| Procalcitonin (PCT) | Uncertain bacterial vs. viral in seriously unwell patients | PCT > 0.25 μg/L suggests bacterial infection; < 0.1 μg/L suggests viral. More specific than CRP for bacterial infection. Useful in guiding antibiotic decisions in borderline cases |
| Blood cultures × 2 | If severe CAP is suspected [6] | Identifies bacteraemia; essential if pneumonia is being treated empirically to allow subsequent targeted therapy |
| Monospot test / EBV serology | Suspected infectious mononucleosis (adolescent with severe pharyngitis, posterior cervical LAP, splenomegaly, fatigue) | Positive heterophile antibodies (Monospot) or EBV-specific IgM |
| Total IgE / allergen-specific IgE / skin prick test | Suspected allergic rhinitis, especially if recurrent "colds" | Elevated total IgE and positive specific IgE to relevant allergens (house dust mite, pollen, etc.) support allergic rhinitis diagnosis |
Pertussis — The White Count Clue
In an infant with a cough illness and an extreme lymphocytosis on CBC, think pertussis. Bordetella pertussis toxin inhibits lymphocyte chemokine receptors, preventing lymphocytes from migrating out of the bloodstream into tissues → accumulation in the blood. This is a classic board-favourite finding.
| Modality | When Indicated | Key Findings / Interpretation |
|---|---|---|
| Chest X-ray (CXR) | Suspected lower respiratory tract infection (tachypnoea, chest signs, hypoxia); not indicated in uncomplicated URTI | Pneumonia: consolidation, air bronchograms, lobar or patchy infiltrates. Bronchiolitis: hyperinflation, peribronchial cuffing, atelectasis. Normal CXR effectively excludes pneumonia (sensitivity ~70% initially; repeat if needed [6]) |
| Neck X-ray (AP + lateral) | Suspected croup (steeple sign) or epiglottitis (thumb sign) — only if diagnosis uncertain and patient stable | Croup: steeple (hourglass) sign — subglottic narrowing on AP view [1]. Epiglottitis: thumb sign — swollen epiglottis on lateral view. CAUTION: in suspected epiglottitis, do NOT delay securing the airway for imaging |
| X-ray sinuses | Suspected sinusitis | Plain films may show sinus fluid levels [3][4]. Poor visualisation of ethmoid sinuses leads to high false-negative rates [3][4]. Generally not recommended as first-line in uncomplicated ARS |
| CT sinuses ± contrast | Preferred imaging modality for sinusitis [3][4] | Common findings include air-fluid levels, mucosal oedema and thickening, air bubbles within sinuses, and opacification [3][4]. CT with contrast is required to identify complications of sinusitis and evaluate disease location and extent of involvement beyond the sinuses [3][4] |
| MRI sinuses | Complicated sinusitis | Useful to delineate extent of soft tissue involvement in patients who have complications of acute rhinosinusitis [3][4] — e.g., orbital cellulitis, intracranial extension |
Why is CT preferred over plain X-ray for sinusitis? Plain films have poor sensitivity, especially for ethmoid sinus disease (the ethmoid cells overlap with other structures on plain radiographs). CT provides excellent bony detail and can show mucosal thickening, air-fluid levels, and ostiomeatal complex obstruction with far greater anatomical precision. However, CT is not routinely indicated for uncomplicated acute rhinosinusitis — it is reserved for cases with suspected complications or chronic/recurrent disease.
These are examination findings that function as diagnostic tools:
| Examination | When to Perform | Key Findings |
|---|---|---|
| Anterior rhinoscopy | All patients with nasal symptoms | Diffuse mucosal oedema, narrowing of middle meatus, inferior turbinate hypertrophy, copious and purulent discharge [3][4]. In allergic rhinitis: pale, boggy turbinates (vs. erythematous in viral URTI) |
| Otoscopy | Indicated in patients with symptoms of ear pain, fullness or pressure, hearing loss or tinnitus [3][4] | Normal TM: pearly grey, light reflex present. AOM: bulging, erythematous TM ± purulent effusion behind TM. Serous otitis media: retracted TM with air-fluid level |
| Oropharyngeal examination | All patients with sore throat | Erythematous pharynx (viral). Tonsillar exudate (GAS, EBV). Vesicles on soft palate (herpangina — enterovirus). Grey membrane (diphtheria — rare) |
| Auscultation of the chest | Any suspicion of lower respiratory tract involvement | Clear lungs → supports URTI. Wheeze → asthma/bronchiolitis. Crackles/bronchial breathing → pneumonia |
| Pulse oximetry (SpO₂) | Any respiratory distress, tachypnoea, or concern for lower tract disease | SpO₂ ≥ 95% normal. < 92% requires urgent assessment and likely supplemental oxygen |
High Yield – Sinus Aspirate / Endoscopic Culture
Sinus aspirate or endoscopic culture of middle meatus is NOT routinely required in diagnosis of ARS and is not commonly available [3][4]. It is reasonable to obtain in patients in whom there is a suspicion of intracranial extension of infection or other serious complication [3][4]. In practice, this is reserved for treatment failures, immunocompromised patients, or nosocomial sinusitis.
| Clinical Scenario | Investigations | Rationale |
|---|---|---|
| Uncomplicated acute coryza | NONE | Self-limiting viral illness; investigations do not change management |
| Suspected influenza | Influenza RAT ± NP PCR | Confirms diagnosis; guides antiviral therapy (oseltamivir within 48h) |
| Suspected COVID-19 | SARS-CoV-2 RAT or RT-PCR | Infection control, isolation, antiviral therapy in high-risk |
| Suspected GAS pharyngitis | Centor criteria → RADT ± throat culture | Guides antibiotic therapy to prevent rheumatic fever |
| Suspected ABRS | Clinical diagnosis primarily; CT sinuses only if complications suspected | ABRS is a clinical diagnosis; imaging is NOT routine |
| Suspected pertussis | NP swab for B. pertussis PCR/culture; CBC (lymphocytosis) | Confirms diagnosis; guides macrolide therapy and public health response |
| Suspected pneumonia | CXR, SpO₂, CBC, CRP, blood cultures if severe | Confirms consolidation; assesses severity; guides antibiotic choice |
| Suspected croup | Clinical diagnosis; neck XR only if diagnosis uncertain | Steeple sign on AP neck XR; avoid imaging if classic presentation |
| Suspected epiglottitis | Secure airway first; lateral neck XR if stable and diagnosis uncertain | Thumb sign; NEVER delay airway management for imaging |
| Recurrent "colds" ?allergic rhinitis | Skin prick test, serum total/specific IgE, anterior rhinoscopy | Identifies atopic aetiology; guides allergen avoidance and treatment |
| Unilateral nasal symptoms in HK adult | Nasopharyngeal examination (nasendoscopy), CT/MRI nasopharynx, EBV serology | Exclude NPC |
| Finding | Suggests |
|---|---|
| Normal CBC, low/normal CRP, self-limiting course | Acute coryza — reassure |
| Neutrophilia + high CRP + persistent/worsening symptoms | Bacterial complication (ABRS, pneumonia, AOM) |
| Marked lymphocytosis in an infant with paroxysmal cough | Pertussis |
| Atypical lymphocytes + positive Monospot | Infectious mononucleosis (EBV) |
| Eosinophilia + elevated IgE + positive skin prick test | Allergic rhinitis |
| CXR showing consolidation / air bronchogram | Pneumonia |
| Steeple sign on AP neck XR | Croup |
| Thumb sign on lateral neck XR | Epiglottitis |
| CT sinuses: air-fluid levels, mucosal thickening | Sinusitis (may be viral or bacterial) |
| NP swab PCR positive for influenza A/B | Influenza — consider oseltamivir if < 48h |
High Yield Summary – Diagnosis and Investigations
- Acute coryza is a clinical diagnosis — no specific diagnostic criteria or tests required
- Uncomplicated cases require NO investigations — the most common exam mistake is over-investigating a cold
- Investigations are only warranted to exclude alternative diagnoses or detect complications
- Three patterns suggest ABRS over viral rhinosinusitis: persistent ≥ 10 days, double worsening after day 5–6, severe onset with high fever ≥ 39°C + purulent discharge for ≥ 3 days
- Centor criteria guide the need for strep testing; absence of cough supports GAS over viral URTI
- NP swab is the optimal specimen for respiratory virus detection (highest viral load in nasopharynx)
- CT sinuses is preferred over plain X-ray when sinusitis imaging is needed (plain films miss ethmoid disease)
- Sinus aspirate/culture is NOT routinely required — only for suspected complications
- CXR is not indicated for uncomplicated URTI — only when lower tract disease is suspected
- Colour of nasal discharge does NOT indicate bacterial infection and does NOT warrant antibiotics
Active Recall - Diagnosis and Investigations of Acute Coryza
References
[1] Senior notes: Adrian Lui Pediatrics Notes.pdf (p.154–161 — URTI spectrum, pertussis, croup) [2] Senior notes: Ryan Ho Respiratory.pdf (p.49–51 — Acute Coryza, red flags) [3] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (p.137–139 — ABRS diagnostic criteria, physical examination, imaging) [4] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (p.113 — ABRS diagnostic criteria, imaging) [6] Senior notes: Maksim Medicine Notes.pdf (p.185–187 — Pneumonia investigations, NP swab indications) [10] Senior notes: Ryan Ho Respiratory.pdf (p.51 — Centor criteria, GAS pharyngitis diagnosis)
Management of Acute Coryza
Before diving into specifics, let's establish the pillars of management from first principles:
Management: ↓stress + rest + infectious control (esp wash hands) ± symptomatic treatment [1][2]
- Acute coryza is a self-limiting viral illness — the body's immune system clears the infection within 7–10 days without any pharmacological intervention
- Antibiotics have NO role — this is a viral infection, not bacterial [3][4]
- Non-pharmacological measures are the most important — sufficient rest, personal hygiene, hand-washing [1]
- Pharmacological treatment is purely symptomatic — it does NOT shorten the duration of illness [2]
- Patient counselling is a cornerstone: explain the viral nature, expected timeline, and when to return [3][4]
High Yield – Core Management Message for Exams
Nature of the disease: viral infection, not bacteria, therefore antibiotics have NO role [3][4]. Self-limiting disease with low morbidity and mortality [3][4]. Treatment is mainly supportive including antipyretics to relieve discomfort, adequate hydration, respiratory support and treatment of complications [3][4].
These measures are the foundation of treatment and should be offered to every patient:
| Measure | Rationale / Mechanism |
|---|---|
| Rest and stress reduction | Psychological stress elevates cortisol → suppresses mucosal IgA and cell-mediated immunity → delays viral clearance. Rest allows metabolic resources to be directed toward immune function |
| Adequate oral hydration | Fever and mouth-breathing increase insensible fluid losses. Adequate hydration keeps mucus thin and easier to clear. In young infants (obligate nasal breathers), nasal obstruction impairs feeding → risk of dehydration |
| Hand-washing | Most effective method in prevention of transmission [1][2]. Disrupts the dominant hand-to-hand/fomite-to-hand transmission route. Alcohol-based hand rub is an acceptable alternative |
| Saline nasal irrigation / drops | Mechanically clears mucus and inflammatory debris; reduces mucosal oedema through mild osmotic effect; restores mucociliary function. Safe in all ages including neonates (isotonic saline drops before feeds to relieve nasal obstruction in infants) |
| Humidified air | May soothe irritated mucosa and reduce cough; evidence is limited but safe |
| Honey (age > 1 year only) | Evidence supports modest benefit for nocturnal cough in children > 1 year. Mechanism: demulcent effect (coats irritated pharyngeal mucosa); may have mild antimicrobial properties. Contraindicated in infants < 1 year due to risk of infantile botulism (Clostridium botulinum spores) |
| Elevated head position during sleep | Reduces post-nasal drip accumulation in the pharynx → less nocturnal cough |
| Avoidance of smoke exposure | Cigarette smoke damages ciliated epithelium and exacerbates airway inflammation, prolonging symptoms |
4. Pharmacological Management — Symptomatic Treatment
The key concept: every drug used in acute coryza targets a specific symptom, NOT the virus itself. None of them shorten the duration of illness [2].
| Drug | Dose | Mechanism | Indications | Contraindications / Cautions |
|---|---|---|---|---|
| Paracetamol (acetaminophen) | Adults: 500mg–1g Q4–6h (max 4g/day). Paediatric: 15mg/kg Q4–6h | Inhibits COX in the CNS → ↓prostaglandin E₂ (PGE₂) synthesis in hypothalamus → ↓thermoregulatory set-point (antipyretic); also has central analgesic effect. Minimal peripheral anti-inflammatory action | Proven to be effective and safe [2]. First-line for fever and pain (sore throat, headache, myalgia) | Hepatotoxicity with overdose (> 150mg/kg in children, > 10g in adults). Caution in liver disease. Dose adjust in severe hepatic impairment |
| NSAIDs (e.g., ibuprofen) | Adults: 200–400mg Q6–8h. Paediatric: 5–10mg/kg Q6–8h | Inhibits COX-1 and COX-2 → ↓peripheral prostaglandin synthesis → anti-inflammatory + analgesic + antipyretic | More effective [than paracetamol] but ↑side effects [2] | Avoided if: (1) not eating well (GI side effects — prostaglandins protect gastric mucosa); (2) aspirin-sensitive asthma; (3) renal dysfunction (prostaglandins maintain renal afferent arteriolar vasodilation); (4) children — risk of Reye syndrome with aspirin specifically [2] |
High Yield – Aspirin and Reye Syndrome
Be cautious with the use of aspirin in febrile children (especially in influenza and VZV infection) due to risk of Reye syndrome [1]. Reye syndrome ("reye" rhymes with "rye") is a rapidly progressive encephalopathy with hepatic dysfunction which often begins several days after apparent recovery from viral illness, characterised by vomiting and confusion and rapidly evolving into seizures and coma [1].
Bottom line: NEVER give aspirin to children < 16 years for antipyresis. Use paracetamol or ibuprofen instead.
Why does aspirin cause Reye syndrome? The exact mechanism is not fully elucidated, but aspirin (a salicylate) is thought to cause mitochondrial dysfunction in hepatocytes and neurons during certain viral infections (especially influenza B and varicella). This leads to microvesicular fatty change in the liver + cerebral oedema. The risk is virtually eliminated by avoiding aspirin in children with febrile viral illnesses.
| Drug | Route | Mechanism | Indications | Cautions / Contraindications |
|---|---|---|---|---|
| Oxymetazoline | Topical nasal spray | α₁-adrenergic agonist → vasoconstriction of submucosal arterioles and venous sinusoids in the nasal turbinates → ↓mucosal oedema → ↓nasal congestion | Significant nasal obstruction interfering with sleep, feeding (infants), or daily function | Rhinitis medicamentosa ("rebound congestion") if used > 3–5 days — chronic use causes tachyphylaxis (receptor downregulation) and rebound vasodilation, leading to worse congestion than the original cold. NOT recommended in children < 6 years. Caution in hypertension (systemic absorption → vasoconstriction → ↑BP) |
| Xylometazoline | Topical nasal spray | Same mechanism as oxymetazoline | Same | Same cautions |
| Pseudoephedrine | Oral | α₁-adrenergic agonist (systemic) → nasal mucosal vasoconstriction | Adult nasal congestion | CNS stimulation (insomnia, anxiety), hypertension, tachycardia, urinary retention (BPH). Contraindicated in uncontrolled HTN, severe CAD, MAOi use. Not recommended in children < 6 years |
Why does topical decongestant cause rebound congestion (rhinitis medicamentosa)? Chronic α₁-agonist exposure → downregulation of α₁-receptors on vascular smooth muscle → loss of vasoconstrictor tone → reflex vasodilation → worsened congestion. The nasal mucosa becomes "dependent" on the spray. Treatment: abrupt discontinuation + short course of intranasal corticosteroids to control the rebound swelling.
| Drug | Generation | Mechanism | Role in Acute Coryza | Cautions |
|---|---|---|---|---|
| Chlorpheniramine | 1st generation | Blocks H₁ receptors → ↓histamine-mediated rhinorrhoea, sneezing. Also has significant anticholinergic effects → ↓nasal secretions (drying effect) | May reduce rhinorrhoea and sneezing by ~30% in adults via anticholinergic drying effect (NOT via anti-allergic mechanism — the common cold is not an IgE-mediated process) | Sedation (crosses BBB → blocks central H₁ receptors involved in wakefulness). Anticholinergic effects: dry mouth, urinary retention, constipation, blurred vision. Caution in elderly (falls), BPH, narrow-angle glaucoma |
| Cetirizine, Loratadine | 2nd generation | Selective peripheral H₁ blockade; minimal anticholinergic effects | NOT effective for the common cold — because they lack the anticholinergic drying effect that is the actual mechanism of symptom relief. Useful for allergic rhinitis (where histamine IS the primary mediator) | Less sedation; generally well-tolerated |
Why do 1st-generation antihistamines help colds but 2nd-generation do not? In allergic rhinitis, histamine (released from mast cells) is the dominant mediator — so any H₁ blocker works. In the common cold, histamine plays a minor role; the runny nose is predominantly driven by bradykinin and parasympathetic reflexes. First-gen antihistamines have potent anticholinergic side effects that dry up secretions — this is what provides the benefit. Second-gen antihistamines were specifically designed to avoid anticholinergic side effects → they don't dry secretions → they don't help colds.
| Agent | Mechanism | Evidence / Comments |
|---|---|---|
| Dextromethorphan | NMDA receptor antagonist → suppresses cough reflex centrally in the medulla | Limited evidence of benefit in acute coryza-associated cough. NOT recommended in children < 6 years (risk of respiratory depression) |
| Codeine | μ-opioid receptor agonist → central cough suppression | NOT recommended in children < 12 years (FDA/EMA); risk of respiratory depression especially in CYP2D6 ultra-rapid metabolisers (convert codeine → morphine too quickly). Constipation, sedation in adults |
| Honey | Demulcent; coats pharyngeal mucosa | Best evidence for nocturnal cough in children > 1 year. Contraindicated < 1 year (botulism risk) |
| Guaifenesin | Expectorant — increases respiratory tract secretion volume to make cough more productive | Very limited evidence of clinical benefit |
| Agent | Mechanism | Evidence |
|---|---|---|
| Aspirin gargle | Local anti-inflammatory and analgesic effect on pharyngeal mucosa | May help sore throat in adults; do NOT swallow (systemic aspirin risks). Not for children |
| Dequalinium bromide lozenge | Antiseptic with mild local anaesthetic properties | No high-quality evidence [2] |
| Lysozyme | Enzyme that hydrolyses bacterial cell wall peptidoglycan | Not recommended [2] — no proven benefit in viral illness |
| Steroids (systemic) | Potent anti-inflammatory | Not recommended [2] for uncomplicated acute coryza — risks outweigh benefits in a self-limiting illness |
| Intranasal ipratropium bromide | Anticholinergic → blocks parasympathetic-driven serous gland secretion | Some evidence for reducing rhinorrhoea (not congestion or sneezing). Not routinely used in most guidelines for the common cold |
| Zinc lozenges | May inhibit viral replication (interferes with rhinovirus binding to ICAM-1); immune-modulatory | Mixed evidence; some meta-analyses show modest reduction in cold duration (~1 day) if started within 24h of symptom onset. Dysgeusia (bad taste) is a common side effect |
| Vitamin C | Antioxidant; immune cell support | Regular supplementation may modestly reduce cold duration (~8% in adults, ~14% in children) but does NOT prevent colds. Therapeutic use after symptom onset shows minimal benefit |
Combination Cold Medicines — A Word of Caution
Combination therapy of analgesics + decongestants + antihistamine + others [1]:
- No evidence for effectiveness for children < 6 years [1]
- ↑ Risk of side effects by shotgun therapy, e.g., antihistamine overdose from cold medicine + cough mixture [1]
In Hong Kong, OTC combination cold medicines (e.g., those containing paracetamol + pseudoephedrine + chlorpheniramine + dextromethorphan) are widely available. The danger is inadvertent double-dosing of paracetamol if the patient takes the combination product AND separate paracetamol. This is a common cause of paracetamol toxicity.
5. Special Populations
- No evidence for effectiveness of combination cold medicines for children < 6 years [1]
- Avoid: codeine (< 12 years), aspirin (< 16 years), topical nasal decongestants (< 6 years in many guidelines)
- Preferred: paracetamol for fever/pain, saline nasal drops (especially before feeds in infants), honey for cough (if > 1 year), adequate hydration, reassurance
- Paracetamol: safe in all trimesters (first-line analgesic/antipyretic)
- NSAIDs: avoid in 3rd trimester (risk of premature closure of ductus arteriosus; oligohydramnios from fetal renal effects)
- Pseudoephedrine: generally avoided (especially 1st trimester — possible association with gastroschisis; also raises BP)
- 1st-gen antihistamines: generally considered safe but sedation may be problematic
- Saline nasal irrigation: safe and recommended
- Paracetamol: first-line; dose adjustment if hepatic impairment
- NSAIDs: use with caution (GI bleeding risk, renal impairment, cardiovascular risk)
- 1st-gen antihistamines: avoid if possible — anticholinergic effects increase fall risk, urinary retention, confusion (Beers criteria)
- Decongestants: caution in hypertension, cardiovascular disease
- Lower threshold for investigation (NP swab for viral panel, bloods)
- Prolonged viral shedding and higher risk of secondary bacterial infection
- Closer follow-up; may require hospitalisation depending on degree of immunosuppression
| Measure | Rationale |
|---|---|
| Hand-washing (soap and water or alcohol-based hand rub) | Most effective prevention method [1][2]; disrupts primary transmission route |
| Cough and sneeze etiquette | Cover mouth/nose with tissue or elbow; dispose of tissues immediately |
| Staying home when febrile | Reduces community transmission; most contagious at onset of symptoms and when febrile [1][2] |
| Wearing a surgical mask | Reduces droplet transmission to close contacts; normalised in Hong Kong post-COVID |
| Regular cleaning of frequently touched surfaces | Rhinovirus can survive on fomites for hours |
| Avoiding close contact with vulnerable individuals | Protect immunocompromised, elderly, neonates |
Call back if [1]:
- Fever lasts ≥ 3 days for children 3 months – 18 years
- New or recurrent fever after initial improvement (double worsening → suspect ABRS)
- Signs of respiratory distress (rapid breathing, chest indrawing, cyanosis)
- Inability to feed or significant dehydration (reduced urine output, dry mucous membranes)
- Ear pain or discharge (suspect AOM)
- Stridor or barking cough (suspect croup)
- Severe sore throat with drooling or difficulty swallowing (suspect epiglottitis — emergency)
- Any deterioration in conscious level (encephalitis, meningitis)
| Complication | Management |
|---|---|
| Acute Otitis Media | Many resolve spontaneously. Antibiotics (amoxicillin) if: age < 2 years with bilateral AOM, AOM with otorrhoea, severe symptoms (fever ≥ 39°C or severe otalgia), or no improvement after 48–72h observation |
| Acute Bacterial Rhinosinusitis | Amoxicillin (first-line) or amoxicillin-clavulanate (if risk of resistant organisms). Duration: 5–10 days. Adjuncts: saline nasal irrigation, intranasal corticosteroids |
| Croup | PO/IM dexamethasone 0.6mg/kg [1] ± nebulised adrenaline 1:1000, 0.5mL/kg (max 5mL) [1]. Severity-guided by Westley score |
| Asthma exacerbation | Inhaled SABA (salbutamol), systemic corticosteroids, follow stepwise asthma management |
| Influenza | Oseltamivir (Tamiflu) — neuraminidase inhibitor; most effective if started within 48h of symptom onset. Indicated for hospitalised patients, severe/complicated illness, and high-risk patients [3][4] |
| COVID-19 | Risk-stratified: supportive care for mild; antivirals (nirmatrelvir/ritonavir preferred) for high-risk within 5 days of onset [6] |
High Yield – Influenza Antivirals: Who Gets Oseltamivir?
Indications for antiviral treatment in influenza [3][4]:
- Hospitalised patients
- Progressive severe or complicated illness
- High-risk patients for developing complications:
- Adults ≥ 65 years
- Pregnant women and women up to 2 weeks post-partum
- Residents of nursing homes or care facilities
- Individuals with chronic medical conditions: pulmonary disease, CVS disease (except isolated HTN), malignancy, chronic liver disease, chronic renal failure, DM, immunosuppression, haemoglobinopathy
| Strategy | Details |
|---|---|
| Hand hygiene | Most effective single measure |
| Seasonal influenza vaccination | Annual vaccination recommended for all ≥ 6 months of age (Hong Kong CHP recommendation); particularly important for high-risk groups. Does NOT prevent the common cold (targets influenza only) but reduces the burden of one important URTI cause |
| COVID-19 vaccination | Updated vaccines as per CHP guidance |
| Healthy lifestyle | Regular moderate exercise, adequate sleep, balanced nutrition, stress management — all support immune function |
| Breastfeeding | Provides secretory IgA and other protective factors; reduces frequency of URTIs in infants |
| No evidence for routine vitamin C or zinc supplementation for prevention | Despite popular belief; regular supplementation may have modest effect on cold duration but does not prevent colds |
| Symptom | First-Line | Mechanism | Key Caution |
|---|---|---|---|
| Fever / Headache / Myalgia | Paracetamol | Central COX inhibition → ↓PGE₂ in hypothalamus | Hepatotoxicity with overdose |
| Sore throat | Paracetamol ± aspirin gargle (adults) | Analgesic ± local anti-inflammatory | No aspirin in children < 16y |
| Nasal congestion | Topical oxymetazoline (adults; ≤ 3–5 days) or saline nasal drops | α₁-agonist → vasoconstriction | Rhinitis medicamentosa if > 3–5 days |
| Rhinorrhoea / Sneezing | 1st-gen antihistamine (adults) | Anticholinergic drying effect | Sedation, urinary retention, dry mouth |
| Cough | Honey (age > 1yr); dextromethorphan (adults) | Demulcent; central cough suppression | Honey: CI < 1yr. Codeine: CI < 12yr |
| Multiple symptoms | Avoid combination OTC products in children < 6yr | N/A | Risk of inadvertent double-dosing (especially paracetamol) |
High Yield Summary – Management of Acute Coryza
- Acute coryza is self-limiting — no antibiotics, no steroids, no antivirals (unless influenza/COVID-19 confirmed)
- Non-pharmacological measures are the cornerstone: rest, hydration, hand-washing, saline nasal drops/irrigation
- Paracetamol is first-line for fever and pain — safe and effective
- NSAIDs are more effective but have more side effects — avoid in children (aspirin → Reye syndrome), renal dysfunction, GI risk, aspirin-sensitive asthma
- 1st-gen antihistamines may reduce rhinorrhoea via anticholinergic effect; 2nd-gen antihistamines do NOT help colds
- Topical nasal decongestants: max 3–5 days to avoid rhinitis medicamentosa
- No combination cold medicines in children < 6 years — no evidence of benefit, increased risk of side effects
- Safety-netting: return if fever ≥ 3 days, double worsening, respiratory distress, inability to feed
- Seasonal influenza vaccination is a key preventive measure for high-risk groups
- Hand-washing remains the single most effective preventive intervention
Active Recall - Management of Acute Coryza
References
[1] Senior notes: Adrian Lui Pediatrics Notes.pdf (p.156 — Acute Coryza management, precautions, Reye syndrome) [2] Senior notes: Ryan Ho Respiratory.pdf (p.49 — Management table, symptomatic treatment evidence) [3] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (p.127–129 — Treatment, patient counselling, indications for antivirals) [4] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (p.103 — Treatment, patient counselling, high-risk groups) [6] Senior notes: Maksim Medicine Notes.pdf (p.201–203 — COVID-19 management, antivirals)
Complications of Acute Coryza
Acute coryza is self-limiting and benign in the vast majority of cases. However, complications arise because viral infection disrupts the normal defence mechanisms of the upper respiratory tract — principally mucociliary clearance, ostial patency, and Eustachian tube function — creating the conditions for secondary bacterial infection or extension of disease to adjacent structures.
Think of it this way: the virus sets the stage, and bacteria or the host's own inflammatory response cause the actual damage.
Complications of acute coryza [1][2]:
- Acute rhinosinusitis due to ↓ mucociliary clearance with viral infection of mucosa
- Lower respiratory involvement due to RSV, parainfluenza, influenza involvement of lungs
- Asthma exacerbation ?due to ↑ airway hyperreactivity with local inflammation
- Acute otitis media (esp in children) due to Eustachian tube dysfunction and bacterial translocation from upper respiratory tract
Complications of runny nose and nasal congestion: otitis media, sinusitis [11]
2. Detailed Complications
2.1 Acute Otitis Media (AOM)
The most common bacterial complication of the common cold, particularly in children.
- Viral infection of the nasopharyngeal mucosa → inflammatory oedema extends to the mucosa lining the Eustachian tube
- The Eustachian tube in children is shorter, more horizontal, and more flaccid than in adults → predisposes to dysfunction
- Mucosal swelling → Eustachian tube obstruction → negative pressure develops in the middle ear (trapped air is absorbed by middle ear mucosa) → serous fluid accumulates (effusion)
- Stasis of fluid + impaired mucociliary clearance → bacterial translocation from the nasopharynx up through the Eustachian tube into the sterile middle ear space
- Common pathogens: S. pneumoniae, non-typeable H. influenzae, M. catarrhalis (the same organisms that cause ABRS — because they originate from the same nasopharyngeal flora)
- Bacterial proliferation in the middle ear effusion → acute suppurative otitis media (pus behind the tympanic membrane)
- Otalgia — the most common symptom; in pre-verbal children manifests as ear pulling, irritability, inconsolable crying
- Otorrhoea — purulent discharge if the tympanic membrane perforates (actually provides pain relief as pressure is released)
- Hearing loss — conductive; due to fluid/pus dampening TM vibration
- Dizziness — inner ear irritation from adjacent middle ear infection
- Fever — may be new-onset or recurrent after initial improvement (the "double worsening" pattern)
- Otoscopy: bulging, erythematous, opaque tympanic membrane ± purulent effusion visible behind TM ± spontaneous perforation with otorrhoea
- Many mild cases resolve spontaneously (watchful waiting for 48–72 hours in children > 2 years with unilateral, non-severe AOM)
- Antibiotics (amoxicillin first-line) indicated for: bilateral AOM in < 2 years, AOM with otorrhoea, severe symptoms (fever ≥ 39°C, severe otalgia), no improvement after observation
- Analgesics (paracetamol/ibuprofen) for pain
- Shorter, more horizontal Eustachian tube → easier bacterial ascent
- Larger adenoids → physical obstruction of Eustachian tube orifice
- Immature immune system → more frequent and prolonged viral URTIs
- More frequent nasopharyngeal colonisation with otopathogens
2.2 Acute Rhinosinusitis
- Viral infection → mucosal oedema of the nasal cavity and sinus ostia (especially the ostiomeatal complex draining the maxillary, anterior ethmoid, and frontal sinuses)
- Ostial obstruction → trapped mucus within the sinus cavity → impaired drainage and mucociliary clearance
- Stagnant mucus in a warm, moist, enclosed space → ideal medium for secondary bacterial overgrowth
- Common pathogens: S. pneumoniae, H. influenzae, M. catarrhalis (same trio as AOM)
- Bacterial infection → purulent sinusitis with intense mucosal inflammation, further oedema, and potentially pressure symptoms (facial pain)
The initial phase (viral rhinosinusitis) is essentially part of the common cold itself — most colds involve some degree of sinus mucosal inflammation visible on CT. Only a small fraction (estimated 0.5–2% of viral URTIs in adults, slightly higher in children) progress to acute bacterial rhinosinusitis (ABRS).
- Persistent nasal congestion and purulent discharge beyond 10 days
- Facial pain/pressure (maxillary = cheek/upper teeth; frontal = forehead; ethmoid = between/behind eyes)
- Post-nasal drip with cough
- Hyposmia/anosmia
- Fever (new-onset or recurrent)
This is where things become genuinely dangerous. The paranasal sinuses are anatomically adjacent to the orbit and the anterior cranial fossa. Infection can spread by direct extension, venous drainage (valveless diploic veins and ophthalmic veins connecting to the cavernous sinus), or through bony erosion.
Complications of acute bacterial rhinosinusitis [12]:
- Orbital cellulitis, abscess
- Cavernous sinus thrombosis
- Intracranial infection: meningitis, encephalitis, abscess
High Yield – GC 215 Complications of ABRS
Complications of acute bacterial rhinosinusitis [12]:
- Orbital cellulitis, abscess — most commonly from ethmoid sinusitis (the lamina papyracea, the paper-thin medial wall of the orbit, is the only barrier between the ethmoid sinuses and the orbit). Presents with periorbital swelling, proptosis, pain with eye movement, restricted extraocular movements, decreased visual acuity. Surgical emergency if abscess forms.
- Cavernous sinus thrombosis — infection spreads via the valveless ophthalmic veins to the cavernous sinus. Presents with bilateral orbital signs (because the two cavernous sinuses communicate), CN III/IV/V₁/V₂/VI palsies, high fever, altered consciousness. Life-threatening.
- Intracranial infection — meningitis, encephalitis, abscess — spread via diploic veins or direct extension through the posterior wall of the frontal sinus (Pott's puffy tumour = subperiosteal abscess of the frontal bone). Presents with headache, altered consciousness, focal neurological deficits, seizures.
| Complication | Source Sinus | Route of Spread | Key Clinical Features |
|---|---|---|---|
| Orbital cellulitis/abscess | Usually ethmoid | Direct through lamina papyracea | Proptosis, ophthalmoplegia, ↓visual acuity, chemosis |
| Cavernous sinus thrombosis | Ethmoid or sphenoid | Valveless ophthalmic veins | Bilateral orbital signs, CN palsies, septic appearance |
| Frontal epidural/subdural abscess | Frontal | Direct through posterior wall | Headache, fever, altered consciousness, focal deficits |
| Brain abscess | Frontal or ethmoid | Direct or haematogenous | Headache, focal deficits, seizures, signs of raised ICP |
| Meningitis | Any sinus | Haematogenous or direct | Neck stiffness, photophobia, altered consciousness |
| Pott's puffy tumour | Frontal | Direct through anterior wall | Forehead swelling, tenderness, osteomyelitis of frontal bone |
2.3 Lower Respiratory Tract Involvement
- Most relevant in infants < 2 years (peak 2–6 months)
- Caused predominantly by RSV (~60–80% of cases)
- Pathophysiology: virus spreads from the upper airway down to the bronchioles → epithelial necrosis → inflammatory cell infiltration and oedema of the bronchiolar wall → mucus plugging of small airways → air trapping (ball-valve mechanism: air enters on inspiration but cannot exit on expiration) + atelectasis (complete obstruction)
- Clinical course: starts as acute coryza (rhinitis, congestion, cough for 1–3 days) → progresses to tachypnoea, subcostal/intercostal recession, wheeze, fine crackles, feeding difficulty, apnoeas (especially in ex-premature infants)
- Management: mainly supportive (oxygen, hydration, nasal suctioning); no proven role for bronchodilators, steroids, or antibiotics in typical bronchiolitis
Long-term sequela: reactive airway disease (recurrent wheezing) is a common sequela reported after bronchiolitis episodes [13].
- Viral pneumonia: direct extension of respiratory virus (influenza, RSV, parainfluenza, adenovirus) to the alveoli → diffuse alveolar damage, interstitial inflammation
- Secondary bacterial pneumonia: viral infection damages airway epithelium and impairs mucociliary clearance → creates portal of entry for bacteria (S. pneumoniae, S. aureus, H. influenzae) → consolidation
- Clue: persistent or new-onset high fever after initial improvement, productive cough with purulent sputum, tachypnoea, focal chest signs (crackles, bronchial breathing, dullness to percussion)
- Extension of viral inflammation to the trachea and large bronchi
- Retrosternal chest tightness, productive cough, low-grade fever
- Distinguished from pneumonia by absence of focal consolidation on examination and CXR
- Self-limiting; supportive management
2.4 Asthma Exacerbation
- Viral URTI (rhinovirus is the #1 trigger for asthma exacerbations, responsible for ~60–80% of virus-induced exacerbations in both children and adults) → direct infection of bronchial epithelium
- Damaged epithelium releases alarmins (IL-25, IL-33, TSLP — thymic stromal lymphopoietin)
- Alarmins activate type 2 innate lymphoid cells (ILC2s) and Th2 lymphocytes → amplification of type 2 inflammation → IL-4, IL-5, IL-13 production
- IL-5 → eosinophil recruitment and activation → release of eosinophil granule proteins (major basic protein, eosinophil cationic protein) → further epithelial damage
- IL-13 → goblet cell hyperplasia (mucus hypersecretion) + smooth muscle contraction
- Overall: bronchospasm + mucosal oedema + mucus plugging → acute airway obstruction → wheeze, cough, SOB, chest tightness
- Step up asthma controller therapy (increase ICS dose ± add SABA as reliever)
- Systemic corticosteroids if moderate–severe exacerbation
- Optimise URTI treatment (supportive)
2.5 Post-Viral (Post-Infectious) Cough
- Viral infection causes damage to the bronchial epithelium → exposes subepithelial vagal sensory nerve endings (C-fibres)
- Transient receptor potential (TRP) channels on these nerve endings become sensitised ("upregulated") by inflammatory mediators
- Even after the virus is cleared and mucosal inflammation subsides, these nerve endings remain hyperexcitable for weeks → persistent cough reflex triggered by minimal stimuli (cold air, talking, laughing, deep breathing)
- No evidence of ongoing infection — sputum culture and CXR are typically normal
- Duration: can persist for 3–8 weeks after the acute illness
- Reassurance — explain the mechanism (nerve hypersensitivity, not ongoing infection)
- No antibiotics (there is no bacterial infection)
- Time → resolves spontaneously
- If very bothersome: trial of inhaled ipratropium (blocks the parasympathetic limb of the cough reflex) or low-dose inhaled corticosteroid (reduces residual airway inflammation)
- If cough persists beyond 8 weeks → investigate for other causes (asthma, GERD, ACEi-related cough, pertussis)
- Not specific to acute coryza but can occur during any febrile illness in children aged 6 months – 5 years (peak 12–18 months)
- Pathophysiology: rapidly rising body temperature → lowers the seizure threshold in the developing brain
- Simple febrile seizure: generalised tonic-clonic, < 15 minutes, single episode within 24 hours, no focal features → benign prognosis, no increased risk of epilepsy
- Complex febrile seizure: focal, prolonged ( > 15 minutes), or recurrent within 24 hours → warrants further investigation
- Mechanism: fever increases insensible fluid losses; nasal obstruction in young infants (who are obligate nasal breathers until ~3–4 months) → difficulty feeding → reduced oral intake → dehydration
- Particularly relevant in breastfed infants who cannot latch effectively when their nose is blocked
- Prevention: frequent small feeds, saline nasal drops before feeds, adequate fluid intake
While croup is technically a specific clinical syndrome rather than a "complication" per se, it represents extension of the same viral infection (parainfluenza, RSV, influenza) from the nasopharynx down to the subglottic region of the larynx.
- Subglottic oedema in a child's narrow airway → inspiratory stridor, barking cough, hoarseness
- Typically preceded by 1–2 days of coryzal symptoms (the "cold" is the prodrome)
- Management: dexamethasone ± nebulised adrenaline depending on severity
| Complication | Mechanism | Comments |
|---|---|---|
| Myocarditis | Viral tropism for myocardium (especially influenza, enterovirus, adenovirus) | Chest pain, tachycardia, heart failure in the context of a recent URTI |
| Guillain-Barré syndrome | Post-infectious autoimmune demyelination of peripheral nerves | Ascending flaccid paralysis 1–4 weeks after respiratory infection |
| Reye syndrome | Mitochondrial dysfunction triggered by aspirin in the setting of viral infection (influenza, VZV) | Now rare due to avoidance of aspirin in children |
| Post-infectious glomerulonephritis | Immune complex deposition following streptococcal infection | Relevant if the URTI was actually GAS pharyngitis, not viral coryza |
| Rheumatic fever | Molecular mimicry between GAS M-protein and cardiac tissue | Only after untreated GAS pharyngitis — not after viral coryza |
| Complication | Relative Frequency | Population Most Affected |
|---|---|---|
| Post-viral cough | Very common | All ages |
| Acute otitis media | Common | Children (especially < 5 years) |
| Acute rhinosinusitis | Common | All ages |
| Asthma exacerbation | Common in asthmatics | Known asthmatics, atopic children |
| Bronchiolitis | Common | Infants < 2 years |
| Pneumonia (viral/bacterial) | Uncommon | Extremes of age, immunocompromised |
| Croup | Uncommon | Children 6 months – 6 years |
| Febrile seizures | Uncommon | Children 6 months – 5 years |
| Dehydration | Uncommon | Young infants |
| Orbital/intracranial complications of sinusitis | Rare | Any age; more common from ethmoid/frontal sinusitis |
| Cavernous sinus thrombosis | Very rare | Any age |
| Myocarditis, GBS, Reye syndrome | Very rare | Various; Reye syndrome specifically children given aspirin |
High Yield Summary – Complications of Acute Coryza
- Most common complication in children: AOM — via Eustachian tube dysfunction and bacterial translocation
- Most common complication overall: post-viral cough — due to persistent sensitisation of vagal C-fibre TRP channels
- Acute rhinosinusitis: ↓mucociliary clearance + ostial obstruction → mucus stasis → secondary bacterial infection (0.5–2% of viral URTIs)
- ABRS can cause life-threatening complications: orbital cellulitis/abscess (from ethmoid sinusitis via lamina papyracea), cavernous sinus thrombosis (via valveless ophthalmic veins), intracranial infection (meningitis, abscess)
- Rhinovirus is the #1 trigger for asthma exacerbations — via epithelial damage → alarmin release → type 2 inflammation amplification
- RSV bronchiolitis: common in infants < 2 years; reactive airway disease is a recognised long-term sequela
- Colour of nasal discharge does NOT indicate bacterial complication — remains a key teaching point
- Aspirin in febrile children → Reye syndrome — always use paracetamol or ibuprofen instead
- Safety-net: new/recurrent fever after improvement ("double worsening") should prompt reassessment for bacterial complications
Active Recall - Complications of Acute Coryza
References
[1] Senior notes: Adrian Lui Pediatrics Notes.pdf (p.156 — Complications of acute coryza) [2] Senior notes: Ryan Ho Respiratory.pdf (p.49 — Complications of acute coryza) [11] Lecture slides: GC 021. Upper respiratory tract infections.pdf (p.20 — Runny nose and nasal congestion: complications) [12] Lecture slides: GC 215. Common nasal conditions and nasopharyngeal carcinoma.pdf (p.22 — Complications of acute bacterial rhinosinusitis) [13] Senior notes: Paediatrics in Review - Bronchiolitis.pdf (p.1, p.9 — Reactive airway disease as sequela of bronchiolitis)
High Yield Summary
Acute Coryza (Common Cold):
- Most common infectious disease in humans; caused by > 200 viral subtypes, predominantly rhinovirus (30–50%)
- Symptoms are caused by the innate immune response (cytokines, bradykinin, PMN infiltration), not direct viral damage
- Colour of nasal discharge does NOT indicate bacterial infection — green/yellow = PMN enzymatic activity (myeloperoxidase), NOT bacteria
- Typical course: 24–72h incubation → peak day 2–3 → resolution in 7–10 days (up to 14 days)
- Hand-washing is the single most effective prevention measure
- Antibiotics are NOT indicated — this is a self-limiting viral illness
- Red flags for complications: new/recurrent fever after improvement (secondary bacterial infection), stridor (croup/epiglottitis), respiratory distress (pneumonia), severe otalgia (AOM)
- Common complications: acute rhinosinusitis, AOM (especially children), asthma exacerbation, lower respiratory tract involvement
- Rhinovirus is the most common trigger for asthma exacerbation
- Distinguish from allergic rhinitis (prominent itch, clear watery discharge, no fever, atopic history)
High Yield Summary – Differential Diagnosis of Acute Coryza
- Most important differentials: Influenza (systemic toxicity, myalgia), GAS pharyngitis (no nasal symptoms, tonsillar exudate), pertussis (paroxysmal cough, no fever), acute bacterial rhinosinusitis (symptoms > 10 days or double worsening), croup (barking cough, stridor), epiglottitis (EMERGENCY — drooling, dysphagia, stridor)
- Non-infectious mimics: Allergic rhinitis (itch, clear discharge, atopy), vasomotor rhinitis, foreign body (unilateral), NPC (Hong Kong — unilateral, blood-stained)
- Lower tract extension: Bronchiolitis (infants, RSV), pneumonia, asthma exacerbation
- GAS pharyngitis is NOT accompanied by nasal symptoms — this is the key distinguishing feature from viral URTI
- Colour of nasal discharge does NOT indicate bacterial infection — do not start antibiotics for green snot alone
- COVID-19 must be considered in the current era; RAT/PCR differentiates
- Use the GC 141 structured approach for paediatric acute cough differentials
High Yield Summary – Diagnosis and Investigations
- Acute coryza is a clinical diagnosis — no specific diagnostic criteria or tests required
- Uncomplicated cases require NO investigations — the most common exam mistake is over-investigating a cold
- Investigations are only warranted to exclude alternative diagnoses or detect complications
- Three patterns suggest ABRS over viral rhinosinusitis: persistent ≥ 10 days, double worsening after day 5–6, severe onset with high fever ≥ 39°C + purulent discharge for ≥ 3 days
- Centor criteria guide the need for strep testing; absence of cough supports GAS over viral URTI
- NP swab is the optimal specimen for respiratory virus detection (highest viral load in nasopharynx)
- CT sinuses is preferred over plain X-ray when sinusitis imaging is needed (plain films miss ethmoid disease)
- Sinus aspirate/culture is NOT routinely required — only for suspected complications
- CXR is not indicated for uncomplicated URTI — only when lower tract disease is suspected
- Colour of nasal discharge does NOT indicate bacterial infection and does NOT warrant antibiotics
High Yield Summary – Management of Acute Coryza
- Acute coryza is self-limiting — no antibiotics, no steroids, no antivirals (unless influenza/COVID-19 confirmed)
- Non-pharmacological measures are the cornerstone: rest, hydration, hand-washing, saline nasal drops/irrigation
- Paracetamol is first-line for fever and pain — safe and effective
- NSAIDs are more effective but have more side effects — avoid in children (aspirin → Reye syndrome), renal dysfunction, GI risk, aspirin-sensitive asthma
- 1st-gen antihistamines may reduce rhinorrhoea via anticholinergic effect; 2nd-gen antihistamines do NOT help colds
- Topical nasal decongestants: max 3–5 days to avoid rhinitis medicamentosa
- No combination cold medicines in children < 6 years — no evidence of benefit, increased risk of side effects
- Safety-netting: return if fever ≥ 3 days, double worsening, respiratory distress, inability to feed
- Seasonal influenza vaccination is a key preventive measure for high-risk groups
- Hand-washing remains the single most effective preventive intervention
High Yield Summary – Complications of Acute Coryza
- Most common complication in children: AOM — via Eustachian tube dysfunction and bacterial translocation
- Most common complication overall: post-viral cough — due to persistent sensitisation of vagal C-fibre TRP channels
- Acute rhinosinusitis: ↓mucociliary clearance + ostial obstruction → mucus stasis → secondary bacterial infection (0.5–2% of viral URTIs)
- ABRS can cause life-threatening complications: orbital cellulitis/abscess (from ethmoid sinusitis via lamina papyracea), cavernous sinus thrombosis (via valveless ophthalmic veins), intracranial infection (meningitis, abscess)
- Rhinovirus is the #1 trigger for asthma exacerbations — via epithelial damage → alarmin release → type 2 inflammation amplification
- RSV bronchiolitis: common in infants < 2 years; reactive airway disease is a recognised long-term sequela
- Colour of nasal discharge does NOT indicate bacterial complication — remains a key teaching point
- Aspirin in febrile children → Reye syndrome — always use paracetamol or ibuprofen instead
- Safety-net: new/recurrent fever after improvement ("double worsening") should prompt reassessment for bacterial complications
Obstructive Sleep Apnea
Obstructive sleep apnea is a sleep disorder characterized by repetitive episodes of partial or complete upper airway collapse during sleep, leading to intermittent hypoxia, sleep fragmentation, and excessive daytime somnolence.
Sinusitis
Sinusitis is inflammation of the paranasal sinus mucosa, typically caused by viral, bacterial, or allergic processes, resulting in obstruction of sinus drainage and accumulation of secretions.